SPXC vs. G, KVYO, RCM, FCFS, TNET, FOUR, VNT, MMS, SPSC, and EXLS
Should you be buying SPX Technologies stock or one of its competitors? The main competitors of SPX Technologies include Genpact (G), Klaviyo (KVYO), R1 RCM (RCM), FirstCash (FCFS), TriNet Group (TNET), Shift4 Payments (FOUR), Vontier (VNT), Maximus (MMS), SPS Commerce (SPSC), and ExlService (EXLS). These companies are all part of the "business services" sector.
Genpact (NYSE:G) and SPX Technologies (NYSE:SPXC) are both mid-cap business services companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, profitability, institutional ownership, community ranking, valuation, earnings, dividends and media sentiment.
96.0% of Genpact shares are owned by institutional investors. Comparatively, 92.8% of SPX Technologies shares are owned by institutional investors. 2.8% of Genpact shares are owned by company insiders. Comparatively, 3.5% of SPX Technologies shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
Genpact received 43 more outperform votes than SPX Technologies when rated by MarketBeat users. Likewise, 68.44% of users gave Genpact an outperform vote while only 59.33% of users gave SPX Technologies an outperform vote.
In the previous week, SPX Technologies had 18 more articles in the media than Genpact. MarketBeat recorded 26 mentions for SPX Technologies and 8 mentions for Genpact. Genpact's average media sentiment score of 0.59 beat SPX Technologies' score of 0.44 indicating that SPX Technologies is being referred to more favorably in the news media.
Genpact currently has a consensus price target of $39.78, indicating a potential upside of 24.66%. SPX Technologies has a consensus price target of $141.00, indicating a potential upside of 2.29%. Given SPX Technologies' higher possible upside, equities analysts clearly believe Genpact is more favorable than SPX Technologies.
Genpact has a net margin of 14.10% compared to Genpact's net margin of 5.32%. SPX Technologies' return on equity of 23.19% beat Genpact's return on equity.
Genpact has higher revenue and earnings than SPX Technologies. Genpact is trading at a lower price-to-earnings ratio than SPX Technologies, indicating that it is currently the more affordable of the two stocks.
Genpact has a beta of 1.07, indicating that its stock price is 7% more volatile than the S&P 500. Comparatively, SPX Technologies has a beta of 1.24, indicating that its stock price is 24% more volatile than the S&P 500.
Summary
Genpact beats SPX Technologies on 10 of the 18 factors compared between the two stocks.
Get SPX Technologies News Delivered to You Automatically
Sign up to receive the latest news and ratings for SPXC and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding SPXC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
SPX Technologies Competitors List
Related Companies and Tools
